(S)-3-IsopropylaMino-piperidine-1-carboxylic acid tert-butyl ester
- $555 - $688
- Product name: (S)-3-IsopropylaMino-piperidine-1-carboxylic acid tert-butyl ester
- CAS: 1163286-38-1
- MF: C13H26N2O2
- MW: 242.36
- EINECS:
- MDL Number:MFCD19381682
- Synonyms:(S)-3-IsopropylaMino-piperidine-1-carboxylic acid tert-butyl ester;(S)-tert-Butyl 3-[(propan-2-yl)amino]piperidine-1-carboxylate;1-Piperidinecarboxylic acid, 3-[(1-methylethyl)amino]-, 1,1-dimethylethyl ester, (3S)-;tert-butyl(S)-3-(isopropylamino)piperidine-1-carboxylate
3 prices
Selected condition:
Brand
- Apolloscientific
- Crysdot
- SynQuest Laboratories
Package
- 1g
- ManufacturerApolloscientific
- Product numberOR62007
- Product description(3S)-3-(Isopropylamino)piperidine, N1-BOC protected
- Packaging1g
- Price$581
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11343218
- Product description(S)-tert-Butyl3-(isopropylamino)piperidine-1-carboxylate 97%
- Packaging1g
- Price$555
- Updated2021-12-16
- Buy
- ManufacturerSynQuest Laboratories
- Product number4H51-1-S9
- Product description(3S)-3-(Isopropylamino)piperidine, N1-Boc protected
- Packaging1g
- Price$688
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Apolloscientific | OR62007 | (3S)-3-(Isopropylamino)piperidine, N1-BOC protected | 1g | $581 | 2021-12-16 | Buy |
Crysdot | CD11343218 | (S)-tert-Butyl3-(isopropylamino)piperidine-1-carboxylate 97% | 1g | $555 | 2021-12-16 | Buy |
SynQuest Laboratories | 4H51-1-S9 | (3S)-3-(Isopropylamino)piperidine, N1-Boc protected | 1g | $688 | 2021-12-16 | Buy |
Properties
Boiling point :317.6±35.0 °C(Predicted)
Density :0.99±0.1 g/cm3(Predicted)
pka :10.10±0.20(Predicted)
form :liquid
color :Clear, faint yellow
Density :0.99±0.1 g/cm3(Predicted)
pka :10.10±0.20(Predicted)
form :liquid
color :Clear, faint yellow
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|